Quick Summary:
In the rapidly advancing healthcare landscape, the global dry eye medication market has emerged as a dynamic sphere of significant growth potential. The demand for dry eye medications is primarily driven by an exponential rise in the number of reported dry eye conditions, largely attributed to aging, prolonged screen exposure, lack of vitamin A, and direct contact with environmental irritants. The market's scope spans across a plethora of products, including polyethylene glycol, polyvinyl alcohol, and propylene glycol among others, which are beginning to gain traction worldwide due to their effectiveness in augmenting eye moisture and treating ocular surface injuries.
With North America holding the largest market share in 2022, and the Middle East predicted as the fastest growing region, the global reach and potential for expansion in this market is undeniable. Moreover, modern techniques and technological innovations, such as hyaluronic acid-based lubricants and lipid emulsions, are enhancing treatment prospects and bolstering market growth. Indeed, purchasing this market research report offers invaluable insights into every facet, trend, and opportunity present in this burgeoning industry, thereby equipping you with the strategic edge required to thrive in the dry eye medication market.
The global dry eye medication market will grow from $8.67 billion in 2022 to $9.62 billion in 2023 at a compound annual growth rate (CAGR) of 11.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The dry eye medication market is expected to grow to $13.99 billion in 2027 at a CAGR of 9.8%.
The dry eye medication market consists of sales of polyethylene glycol, polyvinyl alcohol, propylene glycol, carboxymethylcellulose, povidone, glycerine, and mineral oil. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Dry eye medication refers to the drugs or medication that is used to treat dry eye by increasing your eye moisture. A multifactorial condition of the tears and ocular surface known as dry eye causes symptoms such as pain, blurred vision, and tear film instability, as well as the possibility of ocular surface injury.
North America is the largest region in the dry eye medication market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the dry eye medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The main types of dry eye medication are aqueous dry eye syndrome and evaporative dry eye syndrome. Dry eye syndrome is a frequent problem that arises when the tears aren't able to keep the eyes lubricated enough. Tears may be insufficient and unstable for a variety of causes. The different types of products include liquid drops, gel, liquid wipes, and eye ointment and are used by hospital pharmacies, eye health clinics, retail pharmacies, and online pharmacies.
The increased number of cases of dry eye disease results in an increased demand for its treatment. Factors such as aging, lack of vitamin A, wearing lenses, eye surgeries, direct contact with dry wind or smoke, and exposing one’s eyes to screens for a long duration increase the occurrence of the dry eye more likely. For example, a survey conducted by the American Academy of Ophthalmology reported that in the USA, nearly 3.2 million women and 1.68 million men, over the age of 50 were affected by dry eye syndrome. Similarly, a study conducted by the Indian Journal of Ophthalmology indicated a 32% prevalence of dry eye disease in the Northern part of India. the rising prevalence of the disease would increase the demand for its treatment and ultimately facilitate the growth of this market.
The market for dry eye medication is restricted by the long approval process that is undertaken before any drug is approved by the concerned authority. The standard protocol for testing any new drug demands a series of tests and trials including laboratory tests, animal model tests, and clinical trials. Most drugs fail during clinical trials and only a small percent of them successfully move forward. The cumbersome process of obtaining approvals takes a longer duration of time and restricts the growth of this market. For example, in 2020, Eysuvis, a drug that addresses the short-term treatment needs of patients living with dry eye disease, was approved by the Food and Drug Administration (FDA) after its safety and effectiveness were assessed on more than 2900 patients with the disease in different clinical trials. Similarly, Kissei Pharmaceutical announced to discontinue the development of the KCT-0809 drug after it failed to pass the 3rd phase of clinical trials.
Treatment for dry eye disease improved with the incorporation of modern techniques that helped invent advanced hyaluronic acid-based lubricants and lipid emulsions. This technology replaces artificial tears that include isotonic sodium chloride and provides long-lasting lubrication on the surface of the eye. For instance, Allergan, a global pharmaceutical company, launched Refresh Repair Lubricant Eye Drops which are designed to repair and protect the eyes from dry eye disease and improve the clarity of vision and are formulated with carboxymethylcellulose (CMC), hyaluronic acid, and osmoprotectants. These components maintain the health of the ocular surface and safeguard epithelial cells. Advances in technology will have a positive effect on the market.
The dry eye medication market is strictly regulated by government agencies such as USFDA (Food and Drug Administration), the European Medicines Agency (EMA), and others. For instance, in the USA, FDA evaluates and approves the drugs meant for dry eye treatment. According to Section 201(g) of the FDA and CFR (Code of federal regulations) act, the licenses are granted to drug manufacturing companies allowing them to sell only those drugs that are safe and clinically effective. FDA demands several tests and several clinical trial rounds before granting such approvals. For example, FDA approved Kala Pharmaceuticals’ eye-related drug called INVELTYS.
In July 2022, Alcon, a Switzerland-based ophthalmology company acquired Eysuvis pharmaceutical eye drops from Kala Pharmaceuticals for a deal amount of $60 million. Through this acquisition, Alcon acquires Inveltys treatment of post-operative inflammation and pain following ocular surgery and expands its portfolio. Kala Pharmaceuticals is a US-based pharmacuetical company operating in drug eye medication.
The countries covered in the dry eye medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The dry eye medication market research report is one of a series of new reports that provides dry eye medication market statistics, including dry eye medication industry global market size, regional shares, competitors with a dry eye medication market share, detailed dry eye medication market segments, market trends and opportunities, and any further data you may need to thrive in the dry eye medication industry. This dry eye medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major players in the dry eye medication market are Novartis, Allergan, Otsuka, Santen Pharmaceutical, Auven Therapeutics, Akorn, Valent Pharmaceuticals, Johnson and Johnson Vision, Alcon and Bausch & Lomb.
This product will be delivered within 1-3 business days.
The dry eye medication market consists of sales of polyethylene glycol, polyvinyl alcohol, propylene glycol, carboxymethylcellulose, povidone, glycerine, and mineral oil. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Dry eye medication refers to the drugs or medication that is used to treat dry eye by increasing your eye moisture. A multifactorial condition of the tears and ocular surface known as dry eye causes symptoms such as pain, blurred vision, and tear film instability, as well as the possibility of ocular surface injury.
North America is the largest region in the dry eye medication market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the dry eye medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The main types of dry eye medication are aqueous dry eye syndrome and evaporative dry eye syndrome. Dry eye syndrome is a frequent problem that arises when the tears aren't able to keep the eyes lubricated enough. Tears may be insufficient and unstable for a variety of causes. The different types of products include liquid drops, gel, liquid wipes, and eye ointment and are used by hospital pharmacies, eye health clinics, retail pharmacies, and online pharmacies.
The increased number of cases of dry eye disease results in an increased demand for its treatment. Factors such as aging, lack of vitamin A, wearing lenses, eye surgeries, direct contact with dry wind or smoke, and exposing one’s eyes to screens for a long duration increase the occurrence of the dry eye more likely. For example, a survey conducted by the American Academy of Ophthalmology reported that in the USA, nearly 3.2 million women and 1.68 million men, over the age of 50 were affected by dry eye syndrome. Similarly, a study conducted by the Indian Journal of Ophthalmology indicated a 32% prevalence of dry eye disease in the Northern part of India. the rising prevalence of the disease would increase the demand for its treatment and ultimately facilitate the growth of this market.
The market for dry eye medication is restricted by the long approval process that is undertaken before any drug is approved by the concerned authority. The standard protocol for testing any new drug demands a series of tests and trials including laboratory tests, animal model tests, and clinical trials. Most drugs fail during clinical trials and only a small percent of them successfully move forward. The cumbersome process of obtaining approvals takes a longer duration of time and restricts the growth of this market. For example, in 2020, Eysuvis, a drug that addresses the short-term treatment needs of patients living with dry eye disease, was approved by the Food and Drug Administration (FDA) after its safety and effectiveness were assessed on more than 2900 patients with the disease in different clinical trials. Similarly, Kissei Pharmaceutical announced to discontinue the development of the KCT-0809 drug after it failed to pass the 3rd phase of clinical trials.
Treatment for dry eye disease improved with the incorporation of modern techniques that helped invent advanced hyaluronic acid-based lubricants and lipid emulsions. This technology replaces artificial tears that include isotonic sodium chloride and provides long-lasting lubrication on the surface of the eye. For instance, Allergan, a global pharmaceutical company, launched Refresh Repair Lubricant Eye Drops which are designed to repair and protect the eyes from dry eye disease and improve the clarity of vision and are formulated with carboxymethylcellulose (CMC), hyaluronic acid, and osmoprotectants. These components maintain the health of the ocular surface and safeguard epithelial cells. Advances in technology will have a positive effect on the market.
The dry eye medication market is strictly regulated by government agencies such as USFDA (Food and Drug Administration), the European Medicines Agency (EMA), and others. For instance, in the USA, FDA evaluates and approves the drugs meant for dry eye treatment. According to Section 201(g) of the FDA and CFR (Code of federal regulations) act, the licenses are granted to drug manufacturing companies allowing them to sell only those drugs that are safe and clinically effective. FDA demands several tests and several clinical trial rounds before granting such approvals. For example, FDA approved Kala Pharmaceuticals’ eye-related drug called INVELTYS.
In July 2022, Alcon, a Switzerland-based ophthalmology company acquired Eysuvis pharmaceutical eye drops from Kala Pharmaceuticals for a deal amount of $60 million. Through this acquisition, Alcon acquires Inveltys treatment of post-operative inflammation and pain following ocular surgery and expands its portfolio. Kala Pharmaceuticals is a US-based pharmacuetical company operating in drug eye medication.
The countries covered in the dry eye medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The dry eye medication market research report is one of a series of new reports that provides dry eye medication market statistics, including dry eye medication industry global market size, regional shares, competitors with a dry eye medication market share, detailed dry eye medication market segments, market trends and opportunities, and any further data you may need to thrive in the dry eye medication industry. This dry eye medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major players in the dry eye medication market are Novartis, Allergan, Otsuka, Santen Pharmaceutical, Auven Therapeutics, Akorn, Valent Pharmaceuticals, Johnson and Johnson Vision, Alcon and Bausch & Lomb.
This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Dry Eye Medication Market
What is the estimated value of the Global Dry Eye Medication Market?
What is the growth rate of the Global Dry Eye Medication Market?
What is the forecasted size of the Global Dry Eye Medication Market?
Who are the key companies in the Global Dry Eye Medication Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | February 2023 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value ( USD | $ 9.62 billion |
| Forecasted Market Value ( USD | $ 13.99 billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
Table of Contents
1. Executive Summary2. Dry Eye Medication Market Characteristics
3. Dry Eye Medication Market Trends And Strategies
4. Dry Eye Medication Market - Macro Economic Scenario
4.1 COVID-19 Impact On Dry Eye Medication Market
4.2 Ukraine-Russia War Impact On Dry Eye Medication Market
4.3 Impact Of High Inflation On Dry Eye Medication Market
5. Dry Eye Medication Market Size And Growth
5.1. Global Dry Eye Medication Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Dry Eye Medication Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Dry Eye Medication Market Segmentation
6.1. Global Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Aqueous dry eye syndrome
- Evaporative dry eye syndrome
- Hospital Pharmacies
- Eye Health Clinics
- Retail Pharmacies
- Online Pharmacies
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
7.1. Global Dry Eye Medication Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Dry Eye Medication Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Dry Eye Medication Market
8.1. Asia-Pacific Dry Eye Medication Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.3. Asia-Pacific Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Dry Eye Medication Market
9.1. China Dry Eye Medication Market Overview
9.2. China Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Dry Eye Medication Market
10.1. India Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Dry Eye Medication Market
11.1. Japan Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Dry Eye Medication Market
12.1. Australia Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Dry Eye Medication Market
13.1. Indonesia Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Dry Eye Medication Market
14.1. South Korea Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Dry Eye Medication Market
15.1. Western Europe Dry Eye Medication Market Overview
15.2. Western Europe Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Dry Eye Medication Market
16.1. UK Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Dry Eye Medication Market
17.1. Germany Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Dry Eye Medication Market
18.1. France Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Dry Eye Medication Market
19.1. Eastern Europe Dry Eye Medication Market Overview
19.2. Eastern Europe Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.4. Eastern Europe Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Dry Eye Medication Market
20.1. Russia Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Russia Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Dry Eye Medication Market
21.1. North America Dry Eye Medication Market Overview
21.2. North America Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. North America Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Dry Eye Medication Market
22.1. USA Dry Eye Medication Market Overview
22.2. USA Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.4. USA Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Dry Eye Medication Market
23.1. South America Dry Eye Medication Market Overview
23.2. South America Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. South America Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Dry Eye Medication Market
24.1. Brazil Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. Brazil Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Dry Eye Medication Market
25.1. Middle East Dry Eye Medication Market Overview
25.2. Middle East Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Middle East Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Dry Eye Medication Market
26.1. Africa Dry Eye Medication Market Overview
26.2. Africa Dry Eye Medication Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Dry Eye Medication Market, Segmentation By end-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. Africa Dry Eye Medication Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Dry Eye Medication Market Competitive Landscape And Company Profiles
27.1. Dry Eye Medication Market Competitive Landscape
27.2. Dry Eye Medication Market Company Profiles
27.2.1. Novartis
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Allergan
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Otsuka
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Santen Pharmaceutical
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Auven Therapeutics
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Dry Eye Medication Pipeline Analysis
29. Key Mergers And Acquisitions In The Dry Eye Medication Market
30. Dry Eye Medication Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Historic And Forecast Inflation Rates
31.4. Research Inquiries
31.5. About the Publisher
31.6. Copyright And Disclaimer
Executive Summary
Dry Eye Medication Global Market Report 2023 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on dry eye medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered
1) By Type: Aqueous dry eye syndrome; Evaporative dry eye syndrome2) By end-user: Hospital Pharmacies; Eye Health Clinics; Retail Pharmacies; Online Pharmacies
3) By Product Type: Liquid Drops; Gel; Liquid Wipes; Eye Ointment
Companies Mentioned: Novartis; Allergan; Otsuka; Santen Pharmaceutical; Auven Therapeutics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Novartis
- Allergan
- Otsuka
- Santen Pharmaceutical
- Auven Therapeutics
- Akorn
- Valent Pharmaceuticals
- Johnson and Johnson Vision
- Alcon
- Bausch & Lomb
- I-Med Pharma Inc.
- Sun Pharmaceutical Industries Ltd.
- Sentiss Pharma Pvt. Ltd.
- Reckitt Benckiser Group PLC
- Alcon Laboratories Inc.
- Shire
- Nicox
- Thea
- Novaliq
- Pfizer’s InnoPharma
- Altaire Pharmaceuticals Inc.
- Rayner
- AFT pharmaceuticals
- Kala Pharmaceuticals
- Similasan Corporation
- Abbott Laboratories
- FDC Limited
- Lupin Limited
- OASIS Medical
Methodology
LOADING...
